Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We recruited 973 patients (mean age, 81 years) with atrial fibrillation from the primary care setting and randomly assigned them to receive anticoagulation with warfarin or aspirin. We found that the risk of a fatal or disabling stroke (ischemic or hemorrhagic), intracranial hemorrhage, or clinically significant arterial embolism was 50% lower in the group assigned to warfarin compared with those receiving aspirin. The risk of major hemorrhage in both groups was similar. These findings suggest that, in the absence of contraindications, anticoagulation is the treatment of choice for patients who are older than 75 years and have atrial fibrillation.


Journal article


Cardiology Review

Publication Date





32 - 36